NCT04949555

Brief Summary

evaluation of primary congenital glaucoma management in sohag university hospital

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 16, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

July 2, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

February 9, 2022

Status Verified

February 1, 2022

Enrollment Period

1.2 years

First QC Date

June 16, 2021

Last Update Submit

February 8, 2022

Conditions

Primary Congenital Glaucoma

Keywords

primary congenital glaucoma

Outcome Measures

Primary Outcomes (1)

  • evaluation of patient with primary congenital glaucoma managed in sohag university hospital by surgical intervention,trabeculectomy and trabecultomy with mitomycin and ologen.follow up after management by measuring intra ocular pressure by Perkins.

    retrospective study

    3years

Interventions

Primary congenital glaucoma evaluationOTHER

long term evaluation of primary congenital glaucoma management

Eligibility Criteria

Age3 Months+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patient s with primary congenital glaucoma operated in sohag university hospital

You may qualify if:

  • children operated more than 3 months

You may not qualify if:

  • other types of operated pediatric glaucoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ghada Fathy Mohamed

Sohag, Egypt

RECRUITING

MeSH Terms

Conditions

Hydrophthalmos

Condition Hierarchy (Ancestors)

Eye AbnormalitiesEye DiseasesGlaucoma, Open-AngleGlaucomaOcular HypertensionCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Study Officials

  • ghada f mohamed, MBBCH

    Sohag University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ghada f mohamed, MBBCH

CONTACT

01004720821ghada_fathy_post@med.sohag.edu.eg

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident practitioner of ophthalmology.principal investigator

Study Record Dates

First Submitted

June 16, 2021

First Posted

July 2, 2021

Study Start

January 1, 2021

Primary Completion

March 1, 2022

Study Completion

March 1, 2022

Last Updated

February 9, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations

EG(1)